William R. Shanahan
Keine laufenden Positionen mehr
Karriereverlauf von William R. Shanahan
Ehemalige bekannte Positionen von William R. Shanahan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.08.2016 | 15.04.2018 |
| ARENA PHARMACEUTICALS | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2004 | 13.06.2016 |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2000 | 01.03.2004 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.1994 | 01.08.2000 |
| PFIZER, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1990 | 01.01.1994 |
| Searle Research & Development | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1986 | 01.01.1989 |
| University of Connecticut | Corporate Officer/Principal | - | - |
Ausbildung von William R. Shanahan
| Dartmouth College | Undergraduate Degree |
| Loyola University of Chicago | Graduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 11 |
Operativ
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
| Searle Research & Development |
- Börse
- Insiders
- William R. Shanahan
- Erfahrung